ACST - MCAP CO - Acasti Pharma

Acasti Pharma develops cardiology treatments using an asset-light model to generate royalties, while its financial foundation relies on the delivery of innovative medicines through pharmacy and hospital networks. This price chart captured the indicator at . The business is currently focusing on completing the final stage of clinical trials for the drug ONP-002 to pass mandatory regulatory control.

Market capitalization measures the total value of equity, determining the issuer's investment margin of safety. Analyzing the market value of all Acasti Pharma (ACST) shares allows for a comparison between market expectations and the actual costs of clinical development. In the absence of operating leverage, this metric reflects only the liquid potential to cover fixed costs. The trend of this indicator serves as a gauge of confidence in future molecules, which determines the overall resilience of the asset.